Aveir VR Leadless Pacemaker; Aveir Leadless Pacemaker (Right Atrium); Aveir Leadless Pacemaker (Right Ventricle)
ABBOTT MEDICAL · Decision date Oct 28, 2025
What did the FDA decide?
FDA records P150035/S033 as a supplement to PMA P150035, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 28, 2025.
FDA approval order statement
adding automated X-ray inspection testing of solder joints for the Aveir hybrid
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 28, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P150035/S033
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- PNJ
- Decision code
- OK30
- Decision date
- Oct 28, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Leadless pacemaker.
- Applicant
- Abbott Medical
- Product code
- PNJ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P150035. Subsequent supplements may change the device or its indications.
FDA decision timeline
P150035 · Original PMA
Aveir VR Leadless System
P150035/S029 · Related supplement
AVEIR AR 2 LSP203A Leadless Pacemaker (LP) (atrial)
P150035/S031 · Related supplement
AVEIR Leadless Pacemaker
P150035/S030 · Related supplement
Aveir VR Delivery Catheter LSCD111; Aveir DR Delivery Catheter LSCD201
P150035/S028 · Related supplement
AVEIR Patient Transmitter (model, LSRM01), AVEIR Patient Transmitter Software (model, LSRM1000 v 1.0), AVEIR Patient T
P150035/S033 received
Application receipt date recorded by FDA.
P150035/S032 · Related supplement
AVEIR Leadless Pacemaker Real-time Clock (RTC) electrical test
P150035/S033 · FDA decision
30-Day Notice
P150035/S026 · Related supplement
Aveir VR Leadless Pacemaker, Aveir Leadless Pacemaker (Right Ventricular)
P150035/S034 · Related supplement
Aveir DR Delivery Catheter (LSCD201)
P150035/S036 · Related supplement
AVEIR Leadless Pacemaker, ventricular (LSP112V, LSP202V); Aveir Delivery Catheter (LSCD111, LSCD201)
P150035/S037 · Related supplement
Aveir Leadless System
P150035/S038 · Related supplement
Aveir VR (LSCD111); DR Delivery Catheter (LSCD201)
P150035/S039 · Related supplement
The AVEIR Leadless Pacemaker (LP)
P150035/S040 · Related supplement
AVEIR Patient Transmitter LSRM01
P150035/S035 · Related supplement
Aveir Leadless System
P150035/S041 · Related supplement
Aveir VR Leadless System
P150035/S042 · Related supplement
AVEIR VR Real-World Evidence Study
Timeline entries are records held by MedtechLedger for P150035. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P150035
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Aveir VR Leadless SystemP150035 | ABBOTT MEDICAL | PMA approval | Mar 31, 2022 | FDA |
| ABBOTT MEDICAL | PMA supplement | Aug 15, 2025 | FDA | |
AVEIR Leadless PacemakerP150035/S031 | ABBOTT MEDICAL | PMA supplement | Sep 5, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 17, 2025 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 24, 2025 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 30, 2025 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Feb 19, 2026 | FDA | |
Aveir DR Delivery Catheter (LSCD201)P150035/S034 | ABBOTT MEDICAL | PMA supplement | Feb 23, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Apr 3, 2026 | FDA | |
Aveir Leadless SystemP150035/S037 | ABBOTT MEDICAL | PMA supplement | Apr 24, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | May 29, 2026 | FDA | |
The AVEIR Leadless Pacemaker (LP)P150035/S039 | ABBOTT MEDICAL | PMA supplement | Jun 11, 2026 | FDA |
AVEIR Patient Transmitter LSRM01P150035/S040 | ABBOTT MEDICAL | PMA supplement | Jun 17, 2026 | FDA |
Aveir Leadless SystemP150035/S035 | ABBOTT MEDICAL | PMA supplement | Jul 21, 2026 | FDA |
Aveir VR Leadless SystemP150035/S041 | ABBOTT MEDICAL | PMA supplement | Aug 27, 2026 | FDA |
AVEIR VR Real-World Evidence StudyP150035/S042 | ABBOTT MEDICAL | PMA supplement | Oct 21, 2026 | FDA |
Explore the linked device profile
Other records with product code PNJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Micra Functional Testing on pNGHT and NGHTP150033/S230 | Medtronic, Inc. | PMA supplement | Sep 8, 2026 | FDA |
| Medtronic, Inc. | PMA supplement | Jul 31, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jul 31, 2026 | FDA | |
| Medtronic, Inc. | PMA supplement | Jun 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 15900 Valley View Ct., Sylmar, CA, 91342
Sources and methodology
- Original FDA record: P150035/S033
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records







